Interstitial Lung Disease
Expert Directory
Justin Oldham, MD, MS
Assistant Professor of Medicine
Director, Interstitial Lung Disease Program
University of California, Davis
Sacramento, CA
Justin Oldham, MD, MS, is currently an assistant professor of medicine at the University of California, Davis (UC Davis), where he directs the Interstitial Lung Disease (ILD) Program. Dr Oldham completed his fellowship at the University of Chicago and was then recruited to UC Davis to direct the ILD Program.
He is a clinician-scientist who is interested in biomarker development and implementation. Dr Oldham is currently funded by the National Institutes of Health to study genomic determinants of outcomes in patients with idiopathic pulmonary fibrosis (IPF). His work has included the first drug-gene interaction study performed in IPF (Oldham JM et al. Am J Respir Crit Care Med. 2015;192[12]:1475-1482), and he is currently conducting the first genome-wide association study of survival in patients with IPF. Dr Oldham is also interested in circulating biomarkers of outcomes in ILD, and he has recently published several biomarker investigations in patients with IPF and non-IPF forms of ILD.
Contributing Articles
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis: Challenges and Opportunities in Diagnosis and Treatment
Interstitial Lung Disease
Improving Exercise Tolerance in Patients With Idiopathic Interstitial Pneumonias
Interstitial Lung Disease
Outcome Drivers in Chronic Lung Disease: Comorbidities, Vascular Factors, and Parenchymal Factors
Interstitial Lung Disease
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases
